RE:RE:FDA appointed DSMB leads don't get 400K 46 cent options...Buy low...sell high. So if insiders sell low they suffer the same as Joe Q public so I see where Seto feels there no benefit in a low price in that circumstance.
But, hypothetically, if insiders can buy low when the share price happens to drop or President's List purchasers buy low (F&F?) or options exercised when price is low so capital gains treatment then there is a big benefit for all those fortunate few in those hypothetical situations.
But eventually when the dust settles from this ten million disastrous and avoidable pileup and the innocent bystanders have healed their diluted wounds the damage perhaps will be soothed as the price heads up. Hopefully the 90% earmarked for the US does indeed get sold in the US to people that will promote in the US. And if no other planned disasters exist perhaps attention can be focused on the Catalysts as put forward in the last presentation to shareholders.
Then ultimately all of us sell at a high price. I do recall someone shared recently that Seto said anyone that sells now will really regret that decision. And I think MM also shared that he thought Seto dropped a 3 to 5 month time frame during the AGM. Hope that's all accurate and not out of context.